SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-067594
Filing Date
2023-06-02
Accepted
2023-06-02 16:32:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2314345-11_424b3.htm 424B3 459354
2 GRAPHIC lg_addextherapeutics-4clr.jpg GRAPHIC 68193
  Complete submission text file 0001104659-23-067594.txt   549383
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-271611 | Film No.: 23989410
SIC: 2834 Pharmaceutical Preparations